What You Need to Know About HER2-Negative Breast Cancer

Published: Dec 11, 2023

HER2-negative breast cancer is a common type of breast cancer with unique challenges and treatment options.
Contents

What is HER2-Negative Breast Cancer?

HER2-negative breast cancer is a type of cancer that does not overexpress the HER2 protein. This makes it different from HER2-positive cancers, which often require targeted therapy. Instead, treatment often involves surgery, chemotherapy, and hormonal therapy, depending on the cancer's hormone receptor status.

Treatment Options

The choice of treatment for HER2-negative breast cancer depends on several factors, including tumor size and hormone receptor status. Common treatments include surgery, chemotherapy, and for hormone receptor-positive cancers, endocrine therapy. New research continues to explore additional treatment options and improve outcomes.
HER2-negative breast cancer is a type of cancer that does not overexpress the HER2 protein, requiring treatments such as surgery, chemotherapy, and hormonal therapy.

The Role of Chemotherapy

Chemotherapy is a key treatment for HER2-negative breast cancer, especially for aggressive forms like triple-negative breast cancer. It can help reduce the risk of recurrence and improve survival rates. Patients should discuss the benefits and risks of chemotherapy with their healthcare provider to make informed decisions.

Frequently Asked Questions

It's a type of cancer that doesn't overexpress the HER2 protein.

Treatment includes surgery, chemotherapy, and sometimes endocrine therapy.

It depends on the cancer's characteristics and patient preferences.

Research is ongoing to find new treatment options.

The Bottom Line

Understanding HER2-negative breast cancer is crucial for making informed treatment decisions.
Learn more about your treatment options by consulting with Doctronic today.

Related Articles

References

  1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Comparisons between different polychemotherapy regimens for early breast cancer. Lancet 2012; 379:432.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely